Evidence map›Paper›PMID 33436055›Full record

ArticleJournal of ovarian research2021

Comparison of the predictive value of progesterone-related indicators for pregnancy outcomes of women undergoing the short-acting GnRH agonist long protocol: a retrospective study.

Yangyang Zhang, Yang Xu, Yuqiong Wang, Qing Xue, Jing Shang, Xiuli Yang, Xuemin Shan

Abstract read
In one paragraph

Article in Journal of ovarian research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Impact of aFrontiers in cellular and infection microbiology · 2023
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yangyang ZhangDepartment of Obstetrics & Gynecology, Peking University First Hospital, 100034, Beijing, China.
Yang XuDepartment of Obstetrics & Gynecology, Peking University First Hospital, 100034, Beijing, China. xuyangm@126.com.
Yuqiong WangDepartment of Obstetrics & Gynecology, Peking University First Hospital, 100034, Beijing, China.
Qing XueDepartment of Obstetrics & Gynecology, Peking University First Hospital, 100034, Beijing, China.
Jing ShangDepartment of Obstetrics & Gynecology, Peking University First Hospital, 100034, Beijing, China.
Xiuli YangDepartment of Obstetrics & Gynecology, Peking University First Hospital, 100034, Beijing, China.
Xuemin ShanDepartment of Obstetrics & Gynecology, Peking University First Hospital, 100034, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere are many progesterone (P) elevation-related indicators for predicting pregnancy outcomes, including the serum P, P-to-oestradiol ratio (P/E

methodsA total of 612 infertile women undergoing IVF/ICSI were recruited for this study. Serum samples were obtained on the morning of HCG injection for serum P and E

resultsIn cases of P < 2.5 ng/ml, there was no significant difference in the serum P level or P/E

conclusionsThe PFI and PMOI had equal value in predicting clinical pregnancy outcomes in the normal ovarian response group undergoing the short-acting GnRH agonist long protocol. Each clinical centre can choose one of the indicators according to their actual situation in clinical practice and establish individual cut-off values for PFI and PMOI based on their own hormonal measurements.

Indexed as

AdultFemaleGonadotropin-Releasing HormoneHumansPregnancyProgesteroneRetrospective StudiesGonadotropin-Releasing HormoneProgesteroneP/E2Pregnancy outcomeProgesteroneP‐to‐follicle indexP‐to‐mature oocyte index

Identifiers

PMID33436055
PMCPMC7802138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.